BLACK BOX WARNING
- serious cardiovascular thrombotic events
- serious GI adverse events
- contraindicated for CABG perioperative pain
naproxen
Brand: Aleve, Naprosyn, Anaprox
⚠ BBW Beers Criteria Prototype: ibuprofen
Drug Class: nonsteroidal anti-inflammatory drug (NSAID)
Drug Family: NSAID
Subclass: non-selective COX inhibitor (propionic acid derivative)
Organ Systems: cnsmusculoskeletal
Mechanism of Action
Non-selective COX-1 and COX-2 inhibitor in the propionic acid class with longer duration than ibuprofen due to longer half-life. Maintains anti-inflammatory, analgesic, and antipyretic effects through prostaglandin synthesis inhibition. Among NSAIDs, has the most favorable cardiovascular risk profile.
COX-1COX-2
Indications
- pain
- fever
- dysmenorrhea
- osteoarthritis
- rheumatoid arthritis
- acute gout
- ankylosing spondylitis
Contraindications
- active GI bleeding/ulceration
- severe renal impairment
- aspirin sensitivity
- perioperative CABG pain
- third trimester pregnancy
Adverse Effects
Common
- GI upset
- dyspepsia
- nausea
- edema
Serious
- GI bleeding/ulceration
- AKI
- cardiovascular events (lower risk than other NSAIDs)
- hypertension
Pharmacokinetics (ADME)
| Absorption | well absorbed orally; bioavailability ~95%; food slows absorption minimally |
| Distribution | protein binding >99%; Vd ~0.16 L/kg |
| Metabolism | hepatic CYP1A2 and CYP2C9; inactive metabolites |
| Excretion | renal (95%) |
| Half-life | 12-17 hours (twice daily dosing) |
| Onset | 1 hour |
| Peak | 2-4 hours |
| Duration | 8-12 hours |
| Protein Binding | >99% |
| Vd | 0.16 L/kg |
Drug Interactions
| Drug / Agent | Mechanism | Severity |
|---|---|---|
| anticoagulants | additive bleeding risk | major |
| antihypertensives (ACE inhibitors/ARBs/diuretics) | reduce antihypertensive efficacy; AKI risk | major |
| lithium | reduce renal lithium clearance | major |
Nursing Considerations
- Longer half-life (12-17 hours) allows twice-daily dosing, improving patient adherence compared to every-4-to-6-hour ibuprofen.
- Naproxen has the most favorable cardiovascular risk profile among non-selective NSAIDs; preferred for patients requiring NSAID who have moderate cardiovascular risk.
- Same GI and renal precautions as ibuprofen; use lowest effective dose for shortest duration.
- OTC naproxen sodium (Aleve 220 mg) and prescription naproxen are different salt forms; 220 mg naproxen sodium = 200 mg naproxen base.
Clinical Pearls
- Naproxen has a paradoxically favorable cardiovascular profile relative to other NSAIDs, possibly because its COX-1 antiplatelet effect is prolonged due to its long half-life, partially offsetting COX-2-mediated cardiovascular risk.
- For acute gout, high-dose naproxen (750 mg loading dose, then 250 mg every 8 hours) is equivalent to colchicine and preferred in patients with contraindications to colchicine.
Safety Profile
Pregnancy avoid
Lactation use-with-caution
Renal Adjustment Required
Hepatic Adjustment Required
TDM Not required
Concordance Terms
Cross-referenced clinical concepts — click any term to see all content where it appears.